Header Logo

Connection

LUCILE GREGG to Renal Insufficiency, Chronic

Back to Details
This is a "connection" page, showing publications LUCILE GREGG has written about Renal Insufficiency, Chronic.
LUCILE GREGG
Connection Strength
7.171
Renal Insufficiency, Chronic
  1. A Practical Primer on How to Detect and Treat Depression in CKD. Am J Kidney Dis. 2026 Feb; 87(2):239-245.
    View in: PubMed
    Score: 0.514
  2. Racial and Ethnic Disparities and Facility-Level Variation in GLP-1 RA Prescription among US Veterans with CKD. Clin J Am Soc Nephrol. 2023 11 01; 18(11):1479-1482.
    View in: PubMed
    Score: 0.438
  3. Steroidal or non-steroidal MRAs: should we still enable RAASi use through K binders? Nephrol Dial Transplant. 2023 05 31; 38(6):1355-1365.
    View in: PubMed
    Score: 0.433
  4. Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease. Am J Nephrol. 2023; 54(3-4):126-135.
    View in: PubMed
    Score: 0.432
  5. Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKD. Am J Kidney Dis. 2023 07; 82(1):53-62.e1.
    View in: PubMed
    Score: 0.423
  6. Revisiting diuretic choice in chronic kidney disease. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):406-413.
    View in: PubMed
    Score: 0.407
  7. Diagnosis and Management of Depression in Patients With Kidney Disease. Semin Nephrol. 2021 11; 41(6):505-515.
    View in: PubMed
    Score: 0.388
  8. Considerations in the Study of Body Mass Index Variability. J Am Soc Nephrol. 2021 10; 32(10):2395-2397.
    View in: PubMed
    Score: 0.386
  9. Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5. Hypertension. 2021 03 03; 77(3):948-959.
    View in: PubMed
    Score: 0.367
  10. Pharmacologic and psychological interventions for depression treatment in patients with kidney disease. Curr Opin Nephrol Hypertens. 2020 09; 29(5):457-464.
    View in: PubMed
    Score: 0.358
  11. Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD. Kidney360. 2020 06 25; 1(6):436-446.
    View in: PubMed
    Score: 0.349
  12. Inflammation and Response to Sertraline Treatment in Patients With CKD and Major Depression. Am J Kidney Dis. 2020 03; 75(3):457-460.
    View in: PubMed
    Score: 0.341
  13. Fatigue in Nondialysis Chronic Kidney Disease: Correlates and Association with Kidney Outcomes. Am J Nephrol. 2019; 50(1):37-47.
    View in: PubMed
    Score: 0.329
  14. Association of Monocyte Chemoattractant Protein-1 with Death and Atherosclerotic Events in Chronic Kidney Disease. Am J Nephrol. 2018; 47(6):395-405.
    View in: PubMed
    Score: 0.307
  15. Management of Traditional Cardiovascular Risk Factors in CKD: What Are the Data? Am J Kidney Dis. 2018 11; 72(5):728-744.
    View in: PubMed
    Score: 0.301
  16. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes. J Am Heart Assoc. 2017 Jul 05; 6(7).
    View in: PubMed
    Score: 0.288
  17. Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Res Care. 2021 07; 9(1).
    View in: PubMed
    Score: 0.190
  18. Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation. Am J Kidney Dis. 2025 Jul; 86(1):10-17.
    View in: PubMed
    Score: 0.122
  19. Understanding Prescribing Practices and Patient Experiences with Renin Angiotensin System Inhibitors Use in Chronic Kidney Disease: A Qualitative Study. Cardiorenal Med. 2024; 14(1):34-44.
    View in: PubMed
    Score: 0.113
  20. Improving chronic kidney disease detection and treatment in the United States: the chronic kidney disease cascade of care (C3) study protocol. BMC Nephrol. 2022 10 12; 23(1):331.
    View in: PubMed
    Score: 0.104
  21. Heart failure-type symptom scores in chronic kidney disease: The importance of body mass index. Int J Obes (Lond). 2022 10; 46(10):1910-1917.
    View in: PubMed
    Score: 0.103
  22. Effects of the 2021 CKD-EPI Creatinine eGFR Equation among a National US Veteran Cohort. Clin J Am Soc Nephrol. 2022 02; 17(2):283-285.
    View in: PubMed
    Score: 0.097
  23. Incidence and predictors of non-alcoholic fatty liver disease among patients with chronic kidney disease. Nephrol Dial Transplant. 2021 07 23; 36(8):1546-1548.
    View in: PubMed
    Score: 0.095
  24. Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension. Am J Kidney Dis. 2021 11; 78(5):700-708.e1.
    View in: PubMed
    Score: 0.094
  25. Fatigue in CKD: Epidemiology, Pathophysiology, and Treatment. Clin J Am Soc Nephrol. 2021 09; 16(9):1445-1455.
    View in: PubMed
    Score: 0.093
  26. Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial. JAMA. 2017 11 21; 318(19):1876-1890.
    View in: PubMed
    Score: 0.074
  27. Using dipstick urinalysis to predict development of acute kidney injury in patients with COVID-19. BMC Nephrol. 2022 02 01; 23(1):50.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.